A coalition of health care groups has suggested some legislative and regulatory steps in addressing the drug-
shortage crisis. Among them are creating an early drug-
shortage warning system, streamlining the FDA's approval process, improving communications between stakeholders, and exploring incentives to encourage drug manufacturers to stay in, or re-enter, the market.